Precipio, Inc. (NAS: PRPO) Stock Analysis & Fundamentals | ScreenerHero

Create free account

PRPOPrecipio, Inc.

NAS · US · Healthcare · Diagnostics & Research · precipiodx.com

24.76USD+1.98%Mkt Cap: 44.26M $P/E: —1d ago

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Avg

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap44.26M $

Enterprise Value45.45M $

Revenue (TTM)25.83M $

Gross Profit10.71M $

Net Income (TTM)-363.00K $

Revenue/Share15.42 USD

Last Price24.76 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees61

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS74019L5030

Valuation

P/E (Trailing)—

P/E (Forward)63.49

PEG—

EV/EBITDA-127.66

EV/Revenue1.76

P/S1.71

P/B3.12

EPS (TTM)-0.45

EPS (Forward)0.39

52W Range

10.6061% of range33.63

52W High33.63 USD

52W Low10.60 USD

Profitability

Gross Margin44.52%

Oper. Margin-21.28%

EBITDA Margin-1.38%

Profit Margin-1.51%

ROE-2.49%

ROA-1.70%

Growth

Revenue Growth36.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF793.00K $

CapEx (TTM)326.00K $

FCF Margin2.49%

FCF Yield1.45%

Net Debt888.00K $

Net Debt/EBITDA-2.49

Balance Sheet

Debt/Equity0.25

Current Ratio1.56

Quick Ratio1.21

Book Value/Sh7.943 USD

Cash/Share1.457 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateApr 29, 2019

Splits

Last Split1:20

Split DateSep 22, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.79M

Float1.41M

Insiders12.59%

Institutions17.62%

Short Interest

Short Ratio0.6d

Short % Float1.16%

Short % Out.1.06%

Shares Short18.87K

Short (prev mo.)14.63K

Technical

SMA 5025.74 (-3.8%)

SMA 20023.74 (+4.3%)

Beta1.30

S&P 52W Chg20.05%

Avg Vol (30d)31.18K

Avg Vol (10d)34.09K

Technical Indicators

RSI (14)56.6

MACD-0.4046

MACD Signal-0.7919

MACD Hist.+0.3872

BB Upper24.48 USD

BB Middle23.07 USD

BB Lower21.65 USD

BB Width12.27%

ATR (14)1.336 USD

Vol Ratio (20d)0.52x